Centene Corporation with ticker code (CNC) now have 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $110.00 and $76.00 suggesting an average Analsyt target price of $87.93. Now with the previous closing price of $77.38 and the analysts are correct then there would likely be a percentage uptick in value of 13.6%. Also worth taking note is the 50 day moving average now sits at $73.19 while the 200 day moving average is $68.51. The company has a market capitalization of 41.01B. The stock price for the company is currently is currently $76.76 USD
The potential market cap would be $46,595,933,090 based on the market consensus.
The company has a dividend yield of 1.57%. Other points of data to note are a P/E ratio of 17.02, revenue per share of $253.50 and a 3.85% return on assets.
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
